SCHEMBL7699232

SCHEMBL7699232

CN(C)c1cccc(-c2oc(-c3ccc(C(C)(C)C)cc3)nc2C(=O)Nc2ccccc2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
GAA P10253 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
MAPT P10636 2/20 0.46
RXFP1 Q9HBX9 1/20 0.46
KDM4E B2RXH2 2/20 0.45
SIRT1 Q96EB6 1/20 0.45
DGAT1 O75907 4/20 0.44
KCNK9 Q9NPC2 1/20 0.43
HIF1A Q16665 1/20 0.43
TP53 P04637 1/20 0.43
IKBKB O14920 2/20 0.42
RAB9A P51151 2/20 0.41
MEN1 O00255 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 1/20 0.41
HPGD P15428 2/20 0.40
NPC1 O15118 1/20 0.40
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7701056 0.97 MAPT (0.47) ALDH1A1GAASMN1; SMN2MAPTRXFP1
SCHEMBL7701939 0.90 HSP90AA1 (0.47) ALDH1A1GAASMN1; SMN2MAPTRXFP1
SCHEMBL7699243 0.89 TP53 (0.47) ALDH1A1GAASMN1; SMN2MAPTKDM4E
SCHEMBL7695157 0.87 IKBKB (0.48) ALDH1A1MAPTKDM4ETP53IKBKB
SCHEMBL7698726 0.86 LMNA (0.47) MAPTIKBKBRAB9AMAPK1
SCHEMBL7704094 0.86 MAPT (0.44) ALDH1A1SMN1; SMN2MAPTKDM4ETP53
SCHEMBL7693804 0.85 IKBKB (0.45) ALDH1A1MAPTKDM4EDGAT1TP53
SCHEMBL7695326 0.84 IKBKB (0.40) ALDH1A1GAASMN1; SMN2MAPTRXFP1
SCHEMBL7693979 0.84 IKBKB (0.42) ALDH1A1MAPTRXFP1KDM4ESIRT1
SCHEMBL7697561 0.84 POLB (0.54) ALDH1A1GAASMN1; SMN2KDM4ESIRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002064558-A2 OXAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS CYTOKINE INHIBITORS SANKYO COMPANY, LIMITED (JP) 2002-08-22 WO disclosed